Press release
Central Nervous System Therapeutics Market to grow at a CAGR of 7.4% During the Forecast Period | TechSci Research
Global Central Nervous System Therapeutics Market - TechSci Research
According to TechSci Research report, “Global Central Nervous System Therapeutics Market By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases, Infectious Diseases, CNS Cancer, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospital, Clinics, Diagnostic Laboratories, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region, Competition Forecast & Opportunities, 2026”, the global central nervous system therapeutics market is expected to reach USD125532.90 million in 2026 with a CAGR of 7.4%. The market’s competitive landscape has gotten involved in enhanced research and development of medications for central nervous system illnesses. Furthermore, the increasing focus of governments of several countries towards raising knowledge about the availability of efficient treatment plans for CNS illnesses, is expected to further help the market to flourish in the forecast period.
The global central nervous system therapeutics market is segmented by drug class, application, route of administration, end user, distribution channel, and regional distribution. Based on end User the market is further fragmented into hospital, clinics, diagnostic laboratories, and others. The hospital sub-segment is dominating as well as leading the overall market in the forecast period. Central nervous system disorder involves diseases like Alzheimer’s, Parkinson’s, Epilepsy, Meningitis, etc. These disorders require advanced treatments that require complete observance by medical specialists in hospitals, thereby justifying the dominance of the segment in market.
Browse 158 Figures spread through 110 Pages and an in-depth TOC on "Global Central Nervous System Therapeutics Market.”
https://www.techsciresearch.com/report/central-nervous-system-therapeutics-market/7322.html
The application sub-segment is further segregated into neurodegenerative diseases, mental health and trauma, neurovascular disease, infectious diseases, CNS cancer and others. The mental health and trauma are expected to lead the market during the forecast period. The high prevalence of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Spinal Muscular Atrophy and Huntington’s disease, etc. are the major driving factor for the growth of neurodegenerative diseases segment. Whereas, increasing incidence of depression among youngsters, eating disorders, anxiety disorders, accidents, drugs, and alcohol abuse etc. will directly influence the market in a positive manner in the forecast period. The key growth factors for mental health and trauma subsegment are a large patient population with anxiety disorder and epilepsy. Furthermore, the presence of promising pipeline medications for the management of psychotic disorders is expected to propel the Central Nervous System Therapeutics System forward at a healthy rate throughout the forecast period.
The drug class segment is further segregated into multiple sclerosis, antipsychotic, antiepileptics, analgesics & anesthetics, anti-parkinson and others. The multiple sclerosis is dominating the market accounting for the hight market share of 33.15% in 2020 and is expected to dominate in the forecast period too. Multiple sclerosis is one of the neurodegenerative disorders. According to the Multiple Sclerosis Trust, approximately 2.5 million people were diagnosed with multiple sclerosis in 2017. Women are more affected by MS than males. The condition is most common in adults between the ages of 20 and 40.
On the basis of distribution channel, the market is fragmented into hospital pharmacy, online pharmacy, and retail pharmacy. The online pharmacy is going to lead the market in the forecast period with a significant CAGR of 8.22% due to the convenience and availability of pharmaceutical drugs by e-commerce platforms.
Some of the major competitors in the market are Biogen Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Novartis AG, Sanofi AG, Eli Lilly and Company Ltd., Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Bayer AG, Otsuka Holdings Co. Ltd., Amgen Inc., Bristol Myers Squibb Pharmaceuticals Ltd. among others. The companies are focusing on extensive research and development activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7322
Customers can also request for 10% free customization on this report.
“North American region is the most promising landscape for the future investments. Increasing number of depression and anxiety cases aid the market growth in the region. Since the effective medication and treatment is now feasible and available, the market will grow exponentially and invite governmental support too. Whereas APAC is the leading market in the forecast period due to elevating geriatric population, growing public awareness of mental health issues, as well as government and non-profit activities, are driving market expansion. The incidence of neurodegenerative diseases and other neuroscience disorders will likely elevate the Global Central Nervous System Therapeutics market to a significant level.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Central Nervous System Therapeutics Market By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases, Infectious Diseases, CNS Cancer, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospital, Clinics, Diagnostic Laboratories, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of Global Central nervous system therapeutics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Central nervous system therapeutics market.
Browse Related Reports:
Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market By Sector (Pharmaceutical, Biopharmaceutical), By Product Type (Active Pharmaceutical Ingredients (API), Finished Dosage Formulation (Tablet, Capsule, Oral Liquids, Parenteral/Injectables, Others), Advanced Drug Delivery Products, Over the Counter (OTC) Medicines, Others), By Service (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Biologics Manufacturing Services (Biologics FDF Manufacturing Services, Biologics API Manufacturing Services), Drug Development Services), By Drug Type (Originator / Patented, Generics, Biosimilar), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/pharmaceutical-biopharmaceutical-contract-manufacturing-market/5053.html
Global Antimalarial Drugs Market By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others), By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials), By Route of Administration (Oral, Powder Inhalation, Intravenous Administration), By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi), By Application (Prevention, Treatment of Malaria), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/antimalarial-drugs-market/5012.html
Global Ibuprofen Market, By Product Type (Tablet, Capsule, Syrup and Injection), By Route of Administration (Oral v/s Intravenous), By Application (Rheumatoid Arthritis and Osteoarthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others), By Age Group (Adult v/s Pediatric), By Source (Contract Manufacturing Organizations (CMO), In-House), By End User (Hospitals, Clinics, Others), By Distribution Channel (Offline v/s Online), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/ibuprofen-market/7235.html
About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Central Nervous System Therapeutics Market to grow at a CAGR of 7.4% During the Forecast Period | TechSci Research here
News-ID: 2343483 • Views: …
More Releases from TechSci Research Pvt Ltd
India AI in Medical Diagnostics Market Future Outlook (2024-2030)
India AI in Medical Diagnostics Market Outlook
The India AI in Medical Diagnostics Market, valued at USD 12.87 million in 2024, is poised for significant growth, with a projected compound annual growth rate (CAGR) of 23.10% from 2020 to 2030, reaching an estimated USD 44.87 million by 2030. This robust expansion is driven by the increasing adoption of artificial intelligence (AI) solutions in healthcare, a rising demand for early and accurate…
The Future of Robotic Healthcare Market in India
India Surgical Robotics Market Outlook
The India Surgical Robotics Market, valued at USD 24.72 million in 2024, is on a trajectory of significant growth, projected to reach USD 44.91 million by 2030, driven by a robust compound annual growth rate (CAGR) of 10.42%. This expansion is underpinned by a confluence of factors, including the rising demand for minimally invasive surgeries, advancements in robotic technologies, and the rapid development of healthcare infrastructure…
India Medical Lasers Market: Growth, Trends, and Challenges (2020-2030)
The India Medical Lasers Market is poised for significant growth, projected to expand at a compound annual growth rate (CAGR) of 12.90%, rising from USD 31.20 million in 2024 to USD 64.75 million by 2030. This robust growth is driven by increasing demand for minimally invasive procedures, a rising prevalence of chronic diseases, and supportive government initiatives such as Ayushman Bharat and Make in India. These programs are enhancing healthcare…
India Pneumococcal Vaccine Market Report Outlook 2030 by TechSci Research
Market Outlook: India Pneumococcal Vaccine Market
The India pneumococcal vaccine market is projected to grow from USD 32.52 million in 2024 to USD 48.67 million by 2030, reflecting a CAGR of 6.91%. Growth is being driven by strong government initiatives, such as the inclusion of the Pneumococcal Conjugate Vaccine (PCV) in the Universal Immunization Programme (UIP), rising awareness about pneumonia-related mortality-especially in children-and enhanced local production by domestic manufacturers.
Support from international…
More Releases for Central
Central Lab Market Detailed In New Research Report 2024 | Frontage Laboratories, …
Central Lab Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Central Lab Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Central Lab market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
Central Lab Market Set to Witness Significant Growth by 2024-2031: Eurofins Cent …
Central Lab Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Central Lab Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Central Lab market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful…
Central Valley Prospects Launches Initiative to Highlight Female Basketball Tale …
Central Valley Prospects supports high school female basketball players in Central Valley, showcasing their talents and aiding college recruitment.
Image: https://www.abnewswire.com/uploads/c7e6445a82ef38978dc8415eea8bd321.png
Central Valley Prospects [https://www.cvprospects.com/] has launched an innovative new initiative to spotlight the exceptional talent of high school female basketball players in the Central Valley, a region often overshadowed by the prominent sports markets of Los Angeles and the Bay Area. This program seeks to elevate these athletes' visibility on and…
Central Nervous System Treatment Market - Mental Resurgence: Redefining Central …
Newark, New Castle, USA - new report, titled Central Nervous System Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Central Nervous System Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Central Nervous System Treatment market. The report offers…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Central Air Conditioning (Central A/C Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Central Air Conditioning (Central A/C Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Central Air Conditioning (Central A/C market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$…
